Compounds > thiazoles
Page last updated: 2024-08-21

thiazoles and tanespimycin

thiazoles has been researched along with tanespimycin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asad, Y; Banerji, U; Eccles, SA; Jackman, AL; Judson, I; Raynaud, F; Ruddle, R; Sain, N; Sharp, SY; Valenti, M; Walton, M; Workman, P1
Cools, J; Debiec-Rychter, M; Dewaele, B; Marynen, P; Prenen, H; Schöffski, P; Sciot, R; Vandenberghe, P; Wasag, B; Wozniak, A1
Alcazar, A; Cid, C1
Gu, X; Yang, W; Zhang, J; Zhang, T; Zhao, Y; Zheng, Z1
E, Q; Gao, P; Guo, W; Liu, W; Liu, X; Yan, L; Yang, L; Ye, X; Zuo, J1

Other Studies

5 other study(ies) available for thiazoles and tanespimycin

ArticleYear
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.
    Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:5

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Blotting, Western; Carboplatin; Cell Line, Tumor; Female; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mice; Mice, Nude; Ovarian Neoplasms; Rhodamines; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays

2008
Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutation.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Sep-15, Volume: 14, Issue:18

    Topics: Animals; Benzoquinones; Cell Line, Tumor; Dasatinib; Gastrointestinal Stromal Tumors; Genes, abl; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mice; Mutation; Protein Isoforms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins pp60(c-src); Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Thiazoles; Tumor Cells, Cultured

2008
High cytotoxic sensitivity of the oligodendrocyte precursor cells to HSP90 inhibitors in cell cultures.
    Experimental neurology, 2009, Volume: 216, Issue:2

    Topics: Animals; Benzoquinones; Cell Differentiation; Cell Survival; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Gangliosides; Glial Fibrillary Acidic Protein; HSP90 Heat-Shock Proteins; Inhibitory Concentration 50; Lactams, Macrocyclic; Macrolides; O Antigens; Oligodendroglia; Rats; Stem Cells; Tetrazolium Salts; Thiazoles; Tubulin

2009
The heat shock protein 90 inhibitor 17-AAG suppresses growth and induces apoptosis in human cholangiocarcinoma cells.
    Clinical and experimental medicine, 2013, Volume: 13, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Flow Cytometry; Formazans; Gene Expression Profiling; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Staining and Labeling; Tetrazolium Salts; Thiazoles

2013
Targeting GRP75 improves HSP90 inhibitor efficacy by enhancing p53-mediated apoptosis in hepatocellular carcinoma.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Female; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Liver Neoplasms; Membrane Proteins; Mice; Mice, Nude; Protein Transport; Pyridines; Thiazoles; Tumor Suppressor Protein p53

2014